BlackRock’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $853M | Sell |
|
|||||
|
2025
Q2 | $518M | Buy |
|
|||||
|
2025
Q1 | $626M | Buy |
|
|||||
|
2024
Q4 | $728M | Buy |
|
|||||
|
2024
Q3 | $805M | Buy |
|
|||||
|
2024
Q2 | $795M | Buy |
|
|||||
|
2024
Q1 | $870M | Sell |
|
|||||
|
2023
Q4 | $1.34B | Buy |
|
|||||
|
2023
Q3 | $461M | Buy |
|
|||||
|
2023
Q2 | $501M | Buy |
|
|||||
|
2023
Q1 | $515M | Sell |
|
|||||
|
2022
Q4 | $686M | Buy |
|
|||||
|
2022
Q3 | $706M | Buy |
|
|||||
|
2022
Q2 | $527M | Buy |
|
|||||
|
2022
Q1 | $481M | Buy |
|
|||||
|
2021
Q4 | $590M | Sell |
|
|||||
|
2021
Q3 | $474M | Buy |
|
|||||
|
2021
Q2 | $231M | Sell |
|
|||||
|
2021
Q1 | $277M | Buy |
|
|||||
|
2020
Q4 | $241M | Buy |
|
|||||
|
2020
Q3 | $233M | Buy |
|
|||||
|
2020
Q2 | $221M | Buy |
|
|||||
|
2020
Q1 | $108M | Sell |
|
|||||
|
2019
Q4 | $101M | Buy |
|
|||||
|
2019
Q3 | $105M | Buy |
|
|||||
|
2019
Q2 | $102M | Buy |
|
|||||
|
2019
Q1 | $71.7M | Buy |
|
|||||
|
2018
Q4 | $55.2M | Buy |
|
|||||
|
2018
Q3 | $85.7M | Buy |
|
|||||
|
2018
Q2 | $65.9M | Buy |
|
|||||
|
2018
Q1 | $52.3M | Buy |
|
|||||
|
2017
Q4 | $59M | Buy |
|
|||||
|
2017
Q3 | $99.3M | Buy |
|
|||||
|
2017
Q2 | $75.6M | Buy |
|
|||||
|
2017
Q1 | $39.1M | Buy |
|
|||||
|
2016
Q4 | $40K | Buy |
|
|||||
|
2016
Q3 | $28K | Buy |
|
|||||
|
2016
Q2 | $24K | Buy |
|
|||||
|
2016
Q1 | $15K | Sell |
|
|||||
|
2015
Q4 | $25K | Sell |
|
|||||
|
2015
Q3 | $24K | Buy |
|
|||||
|
2015
Q2 | $5K | Sell |
|
|||||
|
2015
Q1 | $9K | Hold |
|
|||||
|
2014
Q4 | $11K | Hold |
|
|||||
|
2014
Q3 | $5K | Buy |
|
|||||
|
2014
Q2 | $4K | Hold |
|
|||||
|
2014
Q1 | $8K | Buy |
|
|||||
|
2013
Q4 | $4K | Hold |
|
|||||
|
2013
Q3 | $5K | Buy |
|